Dear all,
We have a postdoc position in the AstraZeneca protein structure team, 
Gothenburg.

In this project you will design novel protein constructs and develop expression 
and purification protocols. You will characterize the protein targets abilities 
to bind coregulator peptides, DNA and next-generation drug molecules using a 
wide range of biophysical and structural methods and explore the functional 
consequences in relevant assays using the state-of-the-art AstraZeneca 
facilities.

This project is supported by the Discovery Sciences organization that works 
across all of AstraZeneca’s therapy areas to discover and characterize novel 
drug hits and develop them into candidate drugs. The Protein, Structure and 
Biophysics department works across the entire discovery value chain; 
identifying hits, providing structural activity relationship data for molecular 
differentiation and drug molecule optimization.

For full information about the position and how to apply, please follow the 
link:
https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/Sweden---Gothenburg/Postdoctoral-Fellow---Structure-and-function-of-full-length-nuclear-receptors_R-215656

About AstraZeneca
AstraZeneca is a global, science-led, patient-centred biopharmaceutical company 
focusing on discovering, developing, and commercialising prescription medicines 
for some of the world’s most serious diseases. But we’re more than a global 
leading pharmaceutical company. At AstraZeneca, we're dedicated to being a 
Great Place to Work and empowering employees to push the boundaries of science 
and fuel their entrepreneurial spirit.

About our Postdoc Programme
AstraZeneca’s Postdoc Programme is for self-motivated individuals looking to 
deliver exciting projects in an encouraging, engaging, and innovative 
environment. You'll work with multidisciplinary scientific teams from a diverse 
set of backgrounds and a world-class academic mentor specifically aligned to 
your project. Our postdocs are respected as specialists, encouraged to speak 
up, and supported to share their research at conferences, publish papers, 
achieve their goals.

Best regards,
Karl Edman
Principal Scientist
AstraZeneca

________________________________

Confidentiality Notice: This message is private and may contain confidential 
and proprietary information. If you have received this message in error, please 
notify us and remove it from your system and note that you must not copy, 
distribute or take any action in reliance on it. Any unauthorized use or 
disclosure of the contents of this message is not permitted and may be unlawful.

########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/

Reply via email to